English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 11 July 2019, 11:00 HKT/SGT

Source: Novotech
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

SINGAPORE/TOKYO, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

SuLyn Yip, Novotech Country Manager, and Dr Steven Thng, Executive Director of SRIS, signing the Partnership.

The Partnership formalizes a long-standing working relationship between the two, enabling closer collaboration to ensure the high priority start-up of new projects, and cooperation in clinical trial promotion, business development, networking opportunities, clinical operation, training, and feasibility assessment.

SRIS was established as a collaboration between Agency for Science, Technology and Research (A*STAR), National Healthcare Group (NHG) and Nanyang Technological University (NTU) to conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life.

Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.

Novotech CEO Dr John Moller said the Partnership with SRIS will support the increasing demand from biotech clients for skin disorder studies in the Asia-Pacific region.

Please visit the Skin Research Institute of Singapore (SRIS)at https://www.a-star.edu.sg/sris/About-SRIS.

About Novotech:
Headquartered in Sydney, Novotech CRO is the internationally recognized Asia Pacific contract research organization (CRO) instrumental in hundreds of clinical trials across the region. https://novotech-cro.com/welcome
Check if Asia Pacific is right for your next study: https://novotechcro.typeform.com/to/Uwizka
For RFP enquiries, please fill out the form available at www.novotech-cro.com/contact-us-0

Media contact:
[email protected]
Susan Fitzpatrick-Napier
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427

Topic: Press release summary
Sectors: HealthCare
From the Asia Corporate News Network

Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Novotech Releated News
June 26, 2020 09:00 HKT/SGT
노보텍 (Novotech), 한국의 병상 1,300개 규모 부산대학교병원과 파트너십 체결
June 26, 2020 09:00 HKT/SGT
노보텍 (Novotech) 웨비나: 아시아 태평양 지역이 간학 분야에서 진행 중이거나 예정된 전세계 임상시험의 60%를 유치하는 이유
June 22, 2020 10:00 HKT/SGT
Novotech网络研讨会:亚太地区为什么能够吸引全球 60% 正在进行和计划进行的肝病临床试验
June 22, 2020 10:00 HKT/SGT
Novotech網絡研討會:亞太地區為什麼能夠吸引全球 60% 正在進行和計劃進行的肝病臨床試驗
June 18, 2020 11:00 HKT/SGT
Novotech Partners with South Korea's Pusan National University Hospital
More news >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575